Aridhia, an AlbionVC portfolio company has set up International Covid-19 Data Research Alliance and Workbench to unite leading life science, philanthropic and research organisations to respond to the global pandeminic.
Freeline, a UCL Technology Fund portfolio company has announced a $120m extended Series C financing from existing investors Syncona and new leading biotech funds.
UCL Technology Fund has announced support for the research team at the UCL Cancer Institute. The team are repurposing a sophisticated antibody engineering approach, to research and develop a new treatment against COVID-19.
Impact & opportunities Covid-19 study by Station F, Paris based incubator for start-ups, reveals that 91.3% of businesses have been affected by the crisis.
Join the first AlbionVC webinar: ‘Life Science Software in a Post Covid-19 World'. This webinar looks to assess the short and the long-term implications of the Covid-19 pandemic on the market for clinical trial and real world evidence (RWE) software.
AlbionVC investor Nadine Torbey joins Microsoft UK AI for Good 2020 as a judge at its annual friendly Dragon's Day pitching event. The AI for Good 2020 accelerator programme helps purpose-driven ventures in the UK advance their AI solutions to create positive social transformation.
AlbionVC investment manager Jay Wilson, discusses the challenges and opportunities that have emerged for FinTech founders during the pandemic with Peter Walker from FS Tech.
Discover how AlbionVC and UCL Technology Fund portfolio companies within the AI space are responding to the pandemic.
